Literature DB >> 7518616

Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12.

T Wang1, P K Donahoe, A S Zervos.   

Abstract

Transforming growth factor-beta (TGF-beta) family members bind to receptors that consist of heteromeric serine-threonine kinase subunits (type I and type II). In a yeast genetic screen, the immunophilin FKBP-12, a target of the macrolides FK506 and rapamycin, interacted with the type I receptor for TGF-beta and with other type I receptors. Deletion, point mutation, and co-immunoprecipitation studies further demonstrated the specificity of the interaction. Excess FK506 competed with type I receptors for binding to FKBP-12, which suggests that these receptors share or overlap the macrolide binding site on FKBP-12, and therefore they may represent its natural ligand. The specific interaction between the type I receptors and FKBP-12 suggests that FKBP-12 may play a role in type I receptor-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518616     DOI: 10.1126/science.7518616

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  71 in total

1.  Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Mérino ewes.

Authors:  P Mulsant; F Lecerf; S Fabre; L Schibler; P Monget; I Lanneluc; C Pisselet; J Riquet; D Monniaux; I Callebaut; E Cribiu; J Thimonier; J Teyssier; L Bodin; Y Cognié; N Chitour; J M Elsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  The yeast two-hybrid system and its pharmaceutical significance.

Authors:  Z Topcu; K L Borden
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

Review 3.  Advances in the development of immunosuppressive agents in organ transplantation.

Authors:  T Ochiai; K Isono
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Sp100 interacts with ETS-1 and stimulates its transcriptional activity.

Authors:  Christine Wasylyk; Sophie E Schlumberger; Paola Criqui-Filipe; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 5.  Advances in the current treatment of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

6.  FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae.

Authors:  C M Alarcón; J Heitman
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling.

Authors:  R P Bourette; G M Myles; J L Choi; L R Rohrschneider
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

Review 8.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

9.  Purification and characterization of cytosolic and microsomal cyclophilins from maize (Zea mays).

Authors:  P S Sheldon; M A Venis
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  BMP10 is essential for maintaining cardiac growth during murine cardiogenesis.

Authors:  Hanying Chen; Shu Shi; Lourdes Acosta; Weiming Li; Jonathan Lu; Shideng Bao; Zhuang Chen; Zuocheng Yang; Michael D Schneider; Kenneth R Chien; Simon J Conway; Mervin C Yoder; Laura S Haneline; Diego Franco; Weinian Shou
Journal:  Development       Date:  2004-04-08       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.